课题基金 / 基金详情

Sensory Mechanisms and Self-Injury

Sensory Mechanisms and Self-Injury
感觉机制和自残
批准号:
7784611
负责人:
FRANK J SYMONS
金额:
$38.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-04-01 至 2015-03-31

项目摘要

项目成果

FRANK J SYMONS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):对智力和发育障碍(IDD)个体慢性自伤行为(SIB)的感觉和神经生物学基础知之甚少。在SIB的行为模型中,感觉机制作为假定的积极或消极的自动识别器,但很少有证据直接联系行为和生物学机制。来自慢性疼痛及其行为后遗症的临床和动物研究的证据支持这样的假设,即某些形式的SIB可能受到疼痛机制改变的调节。从我们和其他人的工作中,我们知道疼痛可以导致这一人群中的SIB,但我们几乎不知道慢性SIB是否会导致疼痛以及由此产生的神经免疫级联效应。临床前和临床文献以及研究者的初步数据为慢性SIB的感觉功能障碍和神经病理性疼痛样假说提供了初步支持,并指出了疼痛和炎症/免疫活性的外周和中枢机制的重要作用。本项目的目的是开始测试一种与炎症和免疫系统激活引起的慢性神经病样疼痛相关的SIB新模型。我们假设有一个慢性SI B亚组的个体具有显著的(a)改变的外周感觉神经,(B)增加的炎症和免疫活性,和(c)增加的免疫介导的“疾病”样行为。将采用病例对照设计,比较年龄、性别、智商(IQ)匹配的IDD儿童伴SIB(n = 40)和不伴SIB(n = 40)。将比较各组的(a)外周神经支配(目标1)、(B)炎症/免疫细胞因子和相关肽(目标2)和(c)“疾病”样行为的功能指标,包括适应/社会行为、睡眠/进食和感觉反应性和疼痛体征/症状,以及SI B组内功能和结构变量的比较(目标3)。我们的初步研究结果表明,至少在外周,持续的神经免疫相互作用可能部分与慢性自伤的病理生理学有关。本研究将首次系统地研究IDD儿童SIB相关的神经免疫变量。
英文摘要
DESCRIPTION (provided by applicant): Little is known about the sensory and neurobiological basis of chronic self-injurious behavior (SIB) among individuals with intellectual and developmental disabilities (IDD). In behavioral models of SIB, sensory mechanisms function as putative positive or negative automatic reinforcers but there is little evidence directly linking behavioral and biological mechanisms. Evidence from both clinical and animal studies of chronic pain and its behavioral sequelae supports the hypothesis that some forms of SIB may be regulated by altered pain mechanisms. From our work and that of others, we know that pain can lead to SIB in this population but we know almost nothing about whether chronic SIB leads to pain and the resulting neuro-immune cascade of effects. An established body of preclinical and clinical literature and the investigator's preliminary data provide initial support for a working sensory dysfunction and neuropathic-pain like hypothesis of chronic SIB and point to an important role for the peripheral and central mechanisms of pain and inflammatory/immune activity. The purpose of this project is to begin testing a novel model of SIB in relation to chronic neuropathic-like pain due to inflammatory and immune system activation. We hypothesize that there will be a subgroup of individuals with chronic SIB that have significantly (a) altered peripheral sensory innveration, (b) increased inflammatory and immune activity, and (c) increased immune-mediated 'sickness' like behavior. A case-control design will be used to compare matched (age, gender, IQ) groups of children with IDD with (n = 40) and without SIB (n = 40). The groups will be compared on measures of (a) peripheral innervation (Aim 1), (b) inflammatory/immune cytokines and related peptides (Aim 2), and (c) functional indicators of 'sickness'-like behavior including adaptive/social behavior, sleeping/eating, and sensory reactivity and pain signs/symptoms as well as within SIB group comparisons of functional and structural variables (Aim 3). Our preliminary results suggest that, at least in the periphery, ongoing neuro-immune interactions may, in part, be related to the as of yet poorly understood pathophysiology of chronic self-injury. This study will provide the first opportunity to systematically investigate neuro-immune variables in relation to SIB among children with IDD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sensory Function and Chronic Pain in Cerebral Palsy
  • 批准号:
    10405642
  • 项目类别:
  • 资助金额:
    $48.09万
  • 财政年份:
    2021
  • 负责人:
    FRANK J SYMONS
  • 依托单位:
Sensory Function and Chronic Pain in Cerebral Palsy
  • 批准号:
    10208563
  • 项目类别:
  • 资助金额:
    $52.44万
  • 财政年份:
    2021
  • 负责人:
    FRANK J SYMONS
  • 依托单位:
Intrathecal Baclofen and Pain Outcomes in Cerebral Palsy
  • 批准号:
    9040004
  • 项目类别:
  • 资助金额:
    $48.52万
  • 财政年份:
    2013
  • 负责人:
    FRANK J SYMONS
  • 依托单位:
Intrathecal Baclofen and Pain Outcomes in Cerebral Palsy
  • 批准号:
    8503247
  • 项目类别:
  • 资助金额:
    $49.67万
  • 财政年份:
    2013
  • 负责人:
    FRANK J SYMONS
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: